Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/1996
06/25/1996US5529921 Culturing stable insect cell line capable of assembling antigens and microglobulin proteins into empty complexes, anchoring the empty complexes to the surfaces of cells, culturing, contacting with peptides
06/25/1996US5529898 Methods of detecting disorders of the central nervous system by detecting autoantibodies which specifically bind ionotropic glutamate receptors
06/25/1996CA2034934C Transdermal therapeutic system comprising tulobuterol as active substance
06/23/1996CA2165603A1 3-alkoxybenzylpiperidine derivatives as melatonergic agents
06/20/1996WO1996018648A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection
06/20/1996WO1996018646A2 Heat shock protein peptides and methods for modulating autoimmune central nervous system disease
06/20/1996WO1996018628A1 Alkyl substituted piperadinyl and piperazinyl anti-aids compounds
06/20/1996WO1996018600A1 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
06/20/1996WO1996018399A1 Aryl thioxanthines
06/20/1996WO1996018393A1 Novel compounds
06/20/1996WO1996018391A2 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
06/20/1996WO1996018382A1 Use of flavonoids as immunomodulating or immuno-protective agents in cosmetic and dermatological preparations
06/20/1996WO1996018381A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides
06/20/1996WO1996018380A1 Use of flavonoids for protecting unstable cosmetic active substances and constituents in cosmetic and dermatological formulations
06/20/1996WO1996018379A1 Cosmetic and dermatological preparations with flavonoids
06/20/1996WO1996015234A3 Lipid-splitting enzyme
06/20/1996WO1996012809A3 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
06/20/1996CA2177838A1 A methodology for selecting superagonists, antagonists and superantagonists of human interleukin-6 based on receptor complex three dimensional modelling
06/19/1996EP0717048A1 Cyclic hexapeptides and their mixings, process to synthesize them and their use
06/19/1996EP0717034A1 Vitamin D compounds and method of preparing these compounds
06/19/1996EP0716847A1 Cosmetic or dermatologic compositions containing cinnamic acid derivatives and a flavonoid
06/19/1996EP0716696A1 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease
06/19/1996EP0716693A1 Method and reagent for inhibiting human immunodeficiency virus replication
06/19/1996EP0716692A1 Methods of suppressing autoimmune response
06/19/1996EP0716691A1 Methods of suppressing graft rejection
06/19/1996EP0716658A1 Glycosyl amides of 2-aminoacylamino-2-deoxy sugars
06/19/1996EP0716652A1 Carbocyclic and heterocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
06/19/1996EP0716598A1 Pharmaceutical preparations for the targeted treatment of morbus crohn and colitis ulcerosa
06/19/1996EP0535250B1 Novel compounds and use thereof as medicine
06/19/1996EP0516725B1 New use of linomide (r)
06/19/1996EP0495852B1 Modified biological material
06/19/1996CN1124961A Substituted pyrrolidin-3-Yl-alkyl-piperidines useful as tachykinin antagonists
06/19/1996CN1124738A 7-glycosyloxybenzopyran derivative and antiallergic agent containing the derivative as active ingredient
06/18/1996US5527890 Derivatives of triterpenoid acids and uses thereof
06/18/1996US5527884 Mediators of chronic allograft rejection and DNA molecules encoding them
06/18/1996US5527824 Substituted Di-T-Butlyphenols useful for inhibiting leukotriene synthesis
06/18/1996US5527803 Immunosuppressants, phosphorylase inhibitors
06/18/1996US5527799 HIV protease inhibitors useful for the treatment of AIDS
06/18/1996US5527776 Treatment of immunologic and hematologic disorders with IGFBP alone or complexed with IGF
06/18/1996US5527700 Target antigens of transmission blocking antibodies for malaria parasites
06/18/1996US5527537 Contains natural oils, 3-sn-phosphatidyl choline and/or phosphatidyl ethanolamine and water
06/17/1996CA2165386A1 2-amino-1,3-thiazepines and their use as inhibitors of nitric oxide synthase
06/15/1996CA2164916A1 Vitamin d compounds and method of preparing these compounds
06/13/1996WO1996017935A2 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
06/13/1996WO1996017874A1 Monoclonal antibody fragments having immunosuppressant activity
06/13/1996WO1996017870A1 Identification, purification and uses of leczymes and carbohydrate ligands
06/13/1996WO1996017863A1 Induction of cytotoxic t-lymphocyte responses
06/13/1996WO1996017845A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996WO1996017625A1 Modulating the immune response
06/13/1996WO1996009038A3 Alteration of activity and/or levels of haem-oxygenase to control inflammation
06/13/1996CA2207036A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
06/13/1996CA2207000A1 Modulating the immune response
06/13/1996CA2206965A1 Rapamycin 42-oximes and hydroxylamines
06/13/1996CA2206471A1 Monoclonal antibody fragments having immunosuppressant activity
06/13/1996CA2204738A1 Induction of cytotoxic t-lymphocyte responses
06/12/1996EP0716148A2 Recombinant alphavirus vectors
06/12/1996EP0715849A1 A method of inhibiting endotoxin induced effects
06/12/1996EP0715653A1 Humanised antibodies
06/12/1996EP0715519A1 Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
06/12/1996EP0503044B1 Peptide compounds of laevorotatory amino acids and ring molecules, and therapeutical applications thereof
06/12/1996EP0423201B1 Mhc-mediated conjugates useful in ameliorating autoimmunity
06/12/1996EP0293471B1 Primary biliary cirrhosis autoantigen
06/12/1996CN1124491A Inhibitor of stem cell proliferation and uses thereof
06/12/1996CN1124486A Heterocycle-containing amidine derivatives, their preparation and use
06/12/1996CN1124148A Healthy medicated wine
06/11/1996US5525708 Stabilized protein cell growth and differentiation factors which activate mast cells
06/11/1996US5525629 Inhibition of cytokine production
06/11/1996US5525624 A 3-benzoyl,4-oxyphenylbenzothiophene compound
06/11/1996US5525613 Covalently coupled benzoylecgonine ecgonine and ecgonidine
06/11/1996US5525602 Method of using 4-amino 6-substituted mycophenolic acid and derivatives
06/11/1996US5525590 Immunosuppressants, antiinflammatory and antiparasitic
06/07/1996WO1996017869A2 Interleukin-6 (il-6) antagonists
06/07/1996CA2177837A1 Interleukin-6 (il-6) antagonists
06/06/1996WO1996016990A1 Humanized antibodies to cd38
06/06/1996WO1996016967A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/06/1996WO1996016931A1 Metalloproteinase inhibitors
06/06/1996WO1996016675A2 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors
06/06/1996WO1996016673A1 Method of promoting an immune response with a bispecific antibody
06/06/1996WO1996016666A1 Method for the specific immunoadsorption of selected pathogenic factors
06/06/1996WO1996016653A1 Immunorejection inhibitor
06/06/1996WO1996016642A1 Matrix type patch preparation
06/06/1996CA2207869A1 Method of promoting an immune response with a bispecific antibody
06/06/1996CA2206303A1 Matrix type patch formulation
06/06/1996CA2205972A1 Metalloproteinase inhibitors
06/06/1996CA2205577A1 Hindered n-oxide esters of rapamycin and their use as medicaments
06/05/1996EP0714660A1 Ranolazine and related piperazines for protecting skeletal muscles
06/05/1996EP0714511A1 Methods of detecting and combating disorders of the central nervous system
06/05/1996EP0714442A1 Recombinant alternaria alternata allergenes
06/05/1996EP0714441A1 Recombinant cladosporium herbarum allergens
06/05/1996EP0714440A1 T cell epitopes of ryegrass pollen allergen
06/05/1996EP0714404A1 Anti-inflammatory peptides
06/05/1996EP0714397A1 Phenethylamine compounds
06/05/1996EP0714391A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists
06/05/1996EP0714308A1 Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
06/05/1996EP0714294A1 Pharmaceutical compositions comprising metal complexes
06/05/1996EP0714293A1 3-cyano-3-(3,4-disubstituted)phenylcyclohexyl-1-carboxylates
06/05/1996CN1124027A Ureido derivatives of naphthalenephosphonic acids and process for their preparation
05/1996
05/30/1996WO1996016087A1 G-protein coupled receptor
05/30/1996WO1996016086A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
05/30/1996WO1996016085A1 Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein
1 ... 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 ... 1172